NIMESULIDE-FITOFARM

  • Composition
  • Release form
  • Indication
  • Reception scheme
  • Contraindications
Active substance: nimesulide; excipients: lactose, monohidrant; microcrystalline cellulose, colloidal anhydrous silica, povidion (polyvinylpyrrolidone), croscarmellose sodium, magnesium stearate.
Tablets. 12 tablets in a blister pack in.
Treatment of acute pain, primary dysmenorrhea. Nimesulide should be used only as a second-line drug product. The decision on the appointment of the drug product should be taken on the basis of all the risks to the patient.
The drug product is taken orally after a meal and drink plenty of fluids. Adults. The recommended dose is 100 mg 2 times a day after meals. Patients older. Dose adjustment is required. Adolescents aged 12 to 18 dose adjustment is required. The dosage is the same as for adults. Patients with impaired renal function. Due to the pharmacokinetics of the drug product to patients with mild to moderate renal insufficiency (creatinine clearance - 30-80 mL / min) change the dose required. In severe renal insufficiency (creatinine clearance <30 mL / min), the drug product is contraindicated.
Hypersensitivity to nimesulide or to any component of the drug. History of hyperergic reactions (bronchospasm, rhinitis, urticaria) due to the use of acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs). History of hepatotoxic reactions to nimesulide. Concomitant use of other substances with potential hepatotoxicity. Alcoholism and drug addiction. History of gastrointestinal bleeding or perforation associated with previous use of NSAIDs. Ulcers of the stomach and duodenum in the acute phase, a history of ulcers, perforation or bleeding in the digestive tract. A history of cerebrovascular bleeding or other hemorrhages, as well as diseases accompanied by bleeding. Severe bleeding disorders. Severe heart failure. Severe renal impairment (creatinine clearance <30 ml / min). Liver dysfunction. Patients with fever and / or flu-like symptoms. Severe heart failure. Severe renal impairment (creatinine clearance <30 ml / min). Liver dysfunction. Patients with fever and / or flu-like symptoms. Suspected acute surgical pathology. Do not use concomitantly with other drugs that may cause hepatotoxic reactions. Age up to 12 years. III trimester of pregnancy and lactation.
Price information